Patent · US Active

Long chain base sphingosine kinase inhibitors

US9688668B2 · kind B2 · utility

2Cited by
4References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 8, 2013
Grant dateJun 27, 2017
Priority date
Expiry dateFeb 12, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D271/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to inhibitors of Sphingosine Kinase enzymatic activity, and methods of treating diseases and disorders by administering inhibitors of Sphingosine Kinase enzymatic activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.